Patterson Companies, Inc.

NasdaqGS:PDCO Stock Report

Market Cap: US$2.7b

Patterson Companies Valuation

Is PDCO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PDCO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PDCO ($30.86) is trading below our estimate of fair value ($52.55)

Significantly Below Fair Value: PDCO is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PDCO?

Key metric: As PDCO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PDCO. This is calculated by dividing PDCO's market cap by their current earnings.
What is PDCO's PE Ratio?
PE Ratio17.6x
EarningsUS$155.22m
Market CapUS$2.73b

Price to Earnings Ratio vs Peers

How does PDCO's PE Ratio compare to its peers?

The above table shows the PE ratio for PDCO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.1x
HSIC Henry Schein
27.7x26.7%US$8.6b
CAH Cardinal Health
22.4x7.4%US$28.3b
COR Cencora
29.2x14.8%US$43.7b
MCK McKesson
29x15.0%US$73.5b
PDCO Patterson Companies
17.6x13.0%US$2.7b

Price-To-Earnings vs Peers: PDCO is good value based on its Price-To-Earnings Ratio (17.6x) compared to the peer average (27.1x).

Price to Earnings Ratio vs Industry

How does PDCO's PE Ratio compare vs other companies in the US Healthcare Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
THC Tenet Healthcare
3.9x-39.2%US$11.95b
NEUE NeueHealth
1.1xn/aUS$32.60m
IDXG Interpace Biosciences
2.6xn/aUS$11.71m
FZMD Fuse Medical
2.2xn/aUS$8.67m
PDCO 17.6xIndustry Avg. 21.9xNo. of Companies10PE01632486480+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PDCO is good value based on its Price-To-Earnings Ratio (17.6x) compared to the US Healthcare industry average (21.1x).

Price to Earnings Ratio vs Fair Ratio

What is PDCO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PDCO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.6x
Fair PE Ratio29x

Price-To-Earnings vs Fair Ratio: PDCO is good value based on its Price-To-Earnings Ratio (17.6x) compared to the estimated Fair Price-To-Earnings Ratio (29x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PDCO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$30.86
US$29.68
-3.8%
10.4%US$31.35US$23.00n/a10
Dec ’25US$21.49
US$26.30
+22.4%
8.5%US$30.00US$22.00n/a10
Nov ’25US$20.85
US$26.30
+26.1%
8.5%US$30.00US$22.00n/a10
Oct ’25US$21.08
US$26.40
+25.2%
7.8%US$30.00US$23.00n/a10
Sep ’25US$22.49
US$26.70
+18.7%
7.1%US$30.00US$23.00n/a10
Aug ’25US$25.29
US$28.30
+11.9%
6.7%US$31.00US$25.00n/a10
Jul ’25US$24.08
US$28.64
+18.9%
5.6%US$31.00US$26.00n/a11
Jun ’25US$24.59
US$29.27
+19.0%
5.8%US$32.00US$26.00n/a11
May ’25US$25.45
US$29.73
+16.8%
6.4%US$34.00US$27.00n/a11
Apr ’25US$27.07
US$29.82
+10.2%
6.0%US$34.00US$28.00n/a11
Mar ’25US$27.35
US$29.91
+9.4%
6.1%US$34.00US$28.00n/a11
Feb ’25US$30.08
US$31.00
+3.1%
6.9%US$35.00US$28.00n/a10
Jan ’25US$28.45
US$31.00
+9.0%
9.0%US$37.00US$27.00n/a10
Dec ’24US$26.67
US$31.70
+18.9%
8.9%US$37.00US$27.00US$21.4910
Nov ’24US$30.89
US$35.10
+13.6%
8.1%US$40.00US$32.00US$20.8510
Oct ’24US$29.64
US$35.50
+19.8%
7.5%US$40.00US$32.00US$21.0810
Sep ’24US$30.23
US$35.73
+18.2%
7.4%US$40.00US$32.00US$22.4911
Aug ’24US$33.08
US$35.18
+6.4%
8.5%US$40.00US$31.00US$25.2911
Jul ’24US$33.26
US$35.18
+5.8%
8.5%US$40.00US$31.00US$24.0811
Jun ’24US$26.27
US$31.59
+20.3%
9.6%US$36.00US$27.50US$24.5911
May ’24US$27.30
US$31.59
+15.7%
9.6%US$36.00US$27.50US$25.4511
Apr ’24US$26.77
US$31.59
+18.0%
9.6%US$36.00US$27.50US$27.0711
Mar ’24US$27.02
US$32.50
+20.3%
8.7%US$37.00US$29.00US$27.3511
Feb ’24US$30.53
US$32.95
+7.9%
11.4%US$42.00US$29.00US$30.0811
Jan ’24US$28.03
US$33.05
+17.9%
11.3%US$42.00US$29.00US$28.4511
Dec ’23US$28.73
US$32.32
+12.5%
11.6%US$39.00US$26.00US$26.6711

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 00:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/26
Annual Earnings2024/04/27

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Patterson Companies, Inc. is covered by 37 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Lawrence MarshBarclays
Charley JonesBarrington Research Associates, Inc.